(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

NYKODE THERAPEUTICS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

NYKODE THERAPEUTICS

ST13

US500000079338223

Classe

5, 9, 35, 40, 42, 44

Pedido

79338223

Registro

7203865

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

53

Atualização mais recente

27/09/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 35, 40, 42, 44

Data de depósito

29/11/2021

Data de registro

31/10/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

31/10/2023

Última transação

27/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

63

Localização do titular

NO

Examinador

DIBLE,JONATHON I

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

N. A. (pessoa física)
O. A. (pessoa física)

Representantes

Christian D. Abel Onsagers AS

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 35Classe 40Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceuticals and veterinary preparations for treatment of immune diseasescancertumorsinfectious diseases and viral diseases; sanitary preparations for medical purposes; dietary supplements for humans and animals; Immunotherapeutic preparationsnamely vaccines against immune diseasescancertumorsinfectious diseases and viral diseases; Pharmaceutical preparations for the treatments of cancer; Pharmaceutical preparations for treatment of tumors; anti-cancer pharmaceutical preparations for injections; Radioactive pharmaceutical preparations for radiation treatment; Radioactive substances for medical purposes; Diagnostic preparations for medical and veterinary purposes; pharmaceutical preparations for treatment of infectious diseases; pharmaceutical preparations for treatment of viral diseases; Immunotherapeutic preparationsnamely vaccines against immune diseasescancertumorsinfectious diseases and viral diseases; biological preparations for treatment of cancer; biological preparations for treatment of infectious diseases; biological preparations for treatment of viral diseases; vaccines; immunostimulants; pharmaceutical preparations for treatment of allergies; biological preparations for treatment of allergies; pharmaceutical preparations for treatment of autoimmune diseases; biological preparations for treatment of autoimmune diseases

Classe 9

Laboratory instruments and apparatus for analyzing nucleic acidsDNARNApeptidesproteinslipidspolysaccharidesantigens and antigen presenting cellsfor preparationfiltration and separation of nucleic acidsDNARNApeptidesproteinslipidspoly saccharidesantigens and antigen presenting cellsfor chromatographynot for medical purposes; Downloadable medical software and mobile application for use with immunotherapycompiling medical dataanalyzing test resultsevaluating medical data; Downloadable medical software for designing pharmaceuticals; Downloadable medical software and mobile applications allowing user selection of antigens for designing personalized medicines; Downloadable medical software and mobile applications for user selection of antigens for designing pharmaceuticals

Classe 35

Promoting the goods of otherspharmaceutical productsbiological preparationsmedical diagnostic productsvaccinesanti-cancer pharmaceutical productsimmunotherapeutic pharmaceuticals and products; retail store services featuring pharmaceutical productsbiological preparationsmedical diagnostic productsvaccinesanti-cancer pharmaceutical productsimmunotherapeutic pharmaceuticals and products

Classe 40

Treatment of biological materials for use in production of pharmaceutical preparations by means of culturingexpansionfiltrationpurificationaddition of pharmaceutical excipients and carriersas well as the portioning and packing of those materials; processing and custom manufacturing of pharmaceuticals for others; processing and custom manufacturing of preparations for cancer treatmentpreparations for treatment of tumorsimmunotherapeutic preparationsanti-cancer preparations for injectionradioactive preparations for radiation treatmentradioactive pharmaceuticalsvaccinespreparations for treatment of viral diseasespreparations for treatment of allergiespreparations for treatment of autoimmune diseasesimmunostimulantsbiological preparations for treatment of cancerbiological preparations for treatment of viral diseasesbiological preparations for treatment of allergiesbiological preparations for treatment of autoimmune diseases and medical diagnostic preparations for others

Classe 42

Scientific and technological laboratory services and research and design relating theretoall in the field of pharmaceuticals and vaccines; Industrial analysis and research services in the field of pharmaceuticals and vaccines; design and development of computer hardware and software; designresearch and development of pharmaceuticalspreparations for cancer treatmentpreparations for treatment of tumorsimmunotherapeutic preparationsanti-cancer preparations for injectionradioactive preparations for radiation treatmentradioactive pharmaceuticalsvaccinespreparations for treatment of viral diseasespreparations for treatment of allergiespreparations for treatment of autoimmune diseasesimmunostimulantsbiological preparations for treatment of cancerbiological preparations for treatment of viral diseasesbiological preparations for treatment of allergiesbiological preparations for treatment of autoimmune diseases and medical diagnostic preparations; design and development of medical diagnostic equipment and medical instruments; research and development in the field of medical diagnostic preparations; design and development of medical techniques; Pharmaceutical research and development; Scientific and technological consultancy related to the aforesaid services

Classe 44

Providing information in the field of medicine and health in related to the treatment of tumorsimmunotherapeutic preparationsanti-cancer preparations for injectionradioactive preparations for radiation treatmentradioactive pharmaceuticalsvaccinespreparations for treatment of viral diseasespreparations for treatment of allergiespreparations for treatment of autoimmune diseasesimmunostimulantsbiological preparations for treatment of cancerbiological preparations for treatment of viral diseasesbiological preparations for treatment of allergiesbiological preparations for treatment of autoimmune diseases and diagnostic preparations; medical and pharmaceutical consulting services in the field of treatment of tumorsimmunotherapeutic preparationsanti-cancer preparations for injectionradioactive preparations for radiation treatmentradioactive pharmaceuticalsvaccinespreparations for treatment of viral diseasespreparations for treatment of allergiespreparations for treatment of autoimmune diseasesimmunostimulantsbiological preparations for treatment of cancerbiological preparations for treatment of viral diseasesbiological preparations for treatment of allergiesbiological preparations for treatment of autoimmune diseases and diagnostic preparations; Provision of medical services by health care professionshygiene care for human beings in the field of treatment of tumorsimmunotherapeutic preparationsanti-cancer preparations for injectionradioactive preparations for radiation treatmentradioactive pharmaceuticalsvaccinespreparations for treatment of viral diseasespreparations for treatment of allergiespreparations for treatment of autoimmune diseasesimmunostimulantsbiological preparations for treatment of cancerbiological preparations for treatment of viral diseasesbiological preparations for treatment of allergiesbiological preparations for treatment of autoimmune diseases and diagnostic preparations; medical clinic services

Publicações

Histórico de despachos e eventos da marca no USPTO.

53 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

26/09/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/02/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/02/2024

FIMP

FINAL DISPOSITION PROCESSED

01/02/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

31/01/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

31/10/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

31/10/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

09/10/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

20/09/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

20/09/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/08/2023

PUBO

PUBLISHED FOR OPPOSITION

15/08/2023

GPNX

NOTIFICATION PROCESSED BY IB

14/08/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

26/07/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

26/07/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/07/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/07/2023

DOCK

ASSIGNED TO EXAMINER

11/07/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

05/07/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/07/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

05/07/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/07/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

26/06/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

26/06/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

26/06/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

26/06/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

23/06/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

23/06/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

23/06/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

23/06/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

22/06/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

22/06/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

22/06/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

22/06/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

12/06/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/06/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

12/06/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/06/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/05/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/05/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/05/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/02/2023

RFNT

REFUSAL PROCESSED BY IB

22/12/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

26/11/2022

RFRR

REFUSAL PROCESSED BY MPU

26/11/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

20/09/2022

CNRT

NON-FINAL ACTION WRITTEN

19/09/2022

DOCK

ASSIGNED TO EXAMINER

08/09/2022

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

30/07/2022

CHLD

CHANGE OF OWNER RECEIVED FROM IB

08/05/2022

MAFR

APPLICATION FILING RECEIPT MAILED

22/04/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

18/04/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

14/04/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace NYKODE THERAPEUTICS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.